Inactive Instrument

Perrigo Company Stock price Nasdaq

Equities

US7142901039

Pharmaceuticals

End-of-day quote Nasdaq
- USD 0.00% Intraday chart for Perrigo Company
Sales 2024 * 4.65B Sales 2025 * 4.88B Capitalization 4.26B
Net income 2024 * -35M Net income 2025 * 102M EV / Sales 2024 * 1.6 x
Net Debt 2024 * 3.16B Net Debt 2025 * 2.91B EV / Sales 2025 * 1.47 x
P/E ratio 2024 *
-83.9 x
P/E ratio 2025 *
71.5 x
Employees -
Yield 2024 *
3.5%
Yield 2025 *
3.73%
Free-Float 99.12%
More Fundamentals * Assessed data
Managers TitleAgeSince
Chief Executive Officer 55 23-06-29
Director of Finance/CFO 49 22-05-15
Chief Tech/Sci/R&D Officer - 14-12-31
Members of the board TitleAgeSince
Chairman 55 20-12-14
Director/Board Member 68 17-02-05
Director/Board Member 67 17-02-05
More insiders
Perrigo Company plc is an Ireland-based provider of over the counter (OTC) health and wellness solutions that are designed to enhance individual well-being. The Company's segments include Consumer Self-Care Americas (CSCA) and Consumer Self-Care International (CSCI). The CSCA segment comprises its consumer self-care business (OTC, infant formula, and oral care categories, and contract manufacturing) in the United States and Canada, including the HRA Pharma self-care business (Women's Health and Skin-Care categories) in the United States and Canada. The CSCI segment comprises its consumer self-care business in Europe and Australia, which are primarily branded, its store brand business in the United Kingdom and parts of Europe and Asia and includes the HRA Pharma self-care business (Women's Health, Skin-Care and Rare-Disease categories) in Europe. Its product categories include Upper Respiratory, Pain and Sleep-Aids, Skincare and Personal Hygiene, Digestive Health, Nutrition and others.
Calendar
More about the company
  1. Stock
  2. Equities
  3. Stock Perrigo Company plc
  4. Stock Perrigo Company - Nasdaq